Search results
Earnings call: BioAtla reports promising data in cancer drug trials By Investing.com
Investing.com· 43 minutes agoThe company showcased encouraging results from its CAB-ROR2-ADC drug in treating head and neck...
US FDA extends review of Ascendis Pharma's hormone disorder therapy
Reuters via AOL· 22 hours agoU.S.-listed shares of the company were down 6.6% in late afternoon trading. The health regulator...
The Forces Weighing Against FDA Bans on Toxic Ingredients
Bloomberg· 7 hours agoGood morning, it’s Fiona in New York. The FDA has missed a deadline for a proposed ban on a...
Q1 2024 Dare Bioscience Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 39 minutes agoSo today, in addition to the continued commercialization by our collaborator, Organon of XACIATO clindamycin phosphate vaginal gel 2%, the first FDA-approved product to emerge ...
New Clozapine Data Suggest FDA Should Ease Restrictions
Medscape· 12 hours agoThe risk for severe neutropenia with clozapine is minimal, suggesting that burdensome FDA-required hematologic monitoring should be relaxed, researchers said.
FDA warns some packaged baby food contains potentially toxic metals
WFTV via Yahoo News· 1 day agoParents with newborn babies may want to listen to this new warning from the U.S. Food and Drug...
Elon Musk's Neuralink Was Aware Of Brain Wire Issue For Years: Report
Benzinga via Yahoo Finance· 11 minutes agoNeuralink Corp’s malfunctioning of tiny wires in the brain implant has been known for years, even...
Throw out COVID-19 tests made by San Diego company, FDA warns
FOX 5 San Diego· 56 minutes agoThe U.S. Food and Drug Administration is warning people not to use COVID-19 tests that were...
Vyvo Achieves FDA Approval for Wearable Devices, Merging Blockchain Technology with Healthcare...
Investing.com· 1 day agoVyvo Smart Chain, a HealthFi ecosystem that rewards health tracking through data monetization, today...
US FDA declines expanded use of Dynavax's hepatitis B vaccine on insufficient data
Reuters via Yahoo News· 1 day agoThe Food and Drug Administration in its so-called "complete response letter" stated that the data it...